Logo image of NCNA

NUCANA PLC-ADR (NCNA) Stock Fundamental Analysis

USA - NASDAQ:NCNA - US67022C3043 - ADR

3.55 USD
-0.24 (-6.33%)
Last: 11/13/2025, 3:00:05 PM
Fundamental Rating

2

Taking everything into account, NCNA scores 2 out of 10 in our fundamental rating. NCNA was compared to 531 industry peers in the Biotechnology industry. NCNA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. NCNA has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NCNA had negative earnings in the past year.
In the past year NCNA has reported a negative cash flow from operations.
In the past 5 years NCNA always reported negative net income.
NCNA had a negative operating cash flow in each of the past 5 years.
NCNA Yearly Net Income VS EBIT VS OCF VS FCFNCNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

NCNA has a worse Return On Assets (-195.78%) than 89.83% of its industry peers.
Looking at the Return On Equity, with a value of -430.00%, NCNA is doing worse than 76.08% of the companies in the same industry.
Industry RankSector Rank
ROA -195.78%
ROE -430%
ROIC N/A
ROA(3y)-94.3%
ROA(5y)-72.74%
ROE(3y)-195.95%
ROE(5y)-136.12%
ROIC(3y)N/A
ROIC(5y)N/A
NCNA Yearly ROA, ROE, ROICNCNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

NCNA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NCNA Yearly Profit, Operating, Gross MarginsNCNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

4

2. Health

2.1 Basic Checks

NCNA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NCNA has more shares outstanding
NCNA has a better debt/assets ratio than last year.
NCNA Yearly Shares OutstandingNCNA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NCNA Yearly Total Debt VS Total AssetsNCNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 56.84 indicates that NCNA is not in any danger for bankruptcy at the moment.
NCNA's Altman-Z score of 56.84 is amongst the best of the industry. NCNA outperforms 97.18% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that NCNA is not too dependend on debt financing.
NCNA's Debt to Equity ratio of 0.01 is in line compared to the rest of the industry. NCNA outperforms 43.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 56.84
ROIC/WACCN/A
WACCN/A
NCNA Yearly LT Debt VS Equity VS FCFNCNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

NCNA has a Current Ratio of 1.58. This is a normal value and indicates that NCNA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.58, NCNA is doing worse than 81.73% of the companies in the same industry.
A Quick Ratio of 1.58 indicates that NCNA should not have too much problems paying its short term obligations.
NCNA has a Quick ratio of 1.58. This is amonst the worse of the industry: NCNA underperforms 80.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
NCNA Yearly Current Assets VS Current LiabilitesNCNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

NCNA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.87%, which is quite impressive.
EPS 1Y (TTM)98.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.98%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, NCNA will show a small growth in Earnings Per Share. The EPS will grow by 2.20% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y34%
EPS Next 2Y37.55%
EPS Next 3Y20.95%
EPS Next 5Y2.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NCNA Yearly Revenue VS EstimatesNCNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2029 2030 2031 2032 50M 100M 150M
NCNA Yearly EPS VS EstimatesNCNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -1K -2K -3K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NCNA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NCNA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NCNA Price Earnings VS Forward Price EarningsNCNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NCNA Per share dataNCNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -50 -100 -150 -200 -250

4.3 Compensation for Growth

NCNA's earnings are expected to grow with 20.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.55%
EPS Next 3Y20.95%

More info and screens

0

5. Dividend

5.1 Amount

NCNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NUCANA PLC-ADR

NASDAQ:NCNA (11/13/2025, 3:00:05 PM)

3.55

-0.24 (-6.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-24 2025-11-24/amc
Inst Owners0.24%
Inst Owner Change-16.53%
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.35B
Revenue(TTM)N/A
Net Income(TTM)-31.75M
Analysts82.5
Price TargetN/A
Short Float %0.09%
Short Ratio0.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 139.84
P/tB 199.14
EV/EBITDA N/A
EPS(TTM)-284.41
EYN/A
EPS(NY)-1.6
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS0.03
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -195.78%
ROE -430%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-94.3%
ROA(5y)-72.74%
ROE(3y)-195.95%
ROE(5y)-136.12%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.4%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 56.84
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)70.01%
Cap/Depr(5y)101.29%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.98%
EPS Next Y34%
EPS Next 2Y37.55%
EPS Next 3Y20.95%
EPS Next 5Y2.2%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y10.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.33%
OCF growth 3YN/A
OCF growth 5YN/A

NUCANA PLC-ADR / NCNA FAQ

What is the ChartMill fundamental rating of NUCANA PLC-ADR (NCNA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to NCNA.


Can you provide the valuation status for NUCANA PLC-ADR?

ChartMill assigns a valuation rating of 1 / 10 to NUCANA PLC-ADR (NCNA). This can be considered as Overvalued.


Can you provide the profitability details for NUCANA PLC-ADR?

NUCANA PLC-ADR (NCNA) has a profitability rating of 0 / 10.


What is the financial health of NUCANA PLC-ADR (NCNA) stock?

The financial health rating of NUCANA PLC-ADR (NCNA) is 4 / 10.